Podcast
Turning Pain Into Progress
How Sonia Prashar Built a Mission Around Mental Health
Podcast
Podcast
Gerard Sanacora, Professor at Yale, on glutamate, GABA, and the next era of depression treatment
Brandon Li talks with Dr. Gerard Sanacora, Professor of Psychiatry at Yale, about his journey from molecular physiology to pioneering research on GABA, glutamate, and rapid-acting antidepressants. Gerard shares how a surprising finding in patients undergo
Podcast
Backing Breakthroughs in Psychedelics
Dina Burkitbayeva, CEO of Freedom Biosciences, shares how she launched one of the first venture funds focused on mental health innovation. After co-founding PsyMed Ventures, she partnered with Dr. John Krystal to advance a more durable version of ketamine
Podcast
Joel Raskin, CMO of Arrivo Bio talks about unlocking the future of psychiatry
Brandon Li talks with Joel Raskin, Chief Medical Officer at Arrivo, about his journey from training in psychiatry in Toronto to leading pharmaceutical research in his current role. Joel shares details on SP-624, an Arrivo compound showing promise in treat
Podcast
Dr. Jerry Rosenbaum & Dr. Sharmin Ghaznavi: Mass General Center on the Neuroscience of Psychedelics
In this episode, Dr. Jerry Rosenbaum and Dr. Sharmin Ghaznavi offer a rare look into academia’s role in the psychedelic renaissance, tracing the origins of Mass General’s Center for the Neuroscience of Psychedelics. They discuss how their shared interest
Podcast
Spyros Papapetropoulos, CEO of Neuphoria
Spyros Papapetropoulos, a leading neurologist and neuroscientist, joins Power CEO, Brandon Li, to discuss his remarkable career and the transformative work at Neuphoria. Spyros delves into his transition from practicing neurologist to drug development and
Podcast
Steve Gourlay, CEO of Actinogen
Steve Gourlay joins Power CEO, Brandon Li, to discuss Actinogen's innovative approach to Alzheimer's treatment. Steven shares his background in clinical trials and drug development, highlighting the potential of the company's lead molecule, Xanamem, a dai
Podcast
Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry
In this episode of Power to the Patients, Boehringer Ingelheim leaders Christine Sakdalan and Mike Jablonski from discuss how precision psychiatry—using tools like biomarkers and neuroimaging—can personalize treatment for conditions like schizophrenia and
Podcast
John Krystal: Advancing Ketamine Research & Psychiatry at Yale
John Krystal, Chair of the Department of Psychiatry at Yale, joins Brandon Li to discuss his groundbreaking work on ketamine's antidepressant effects and the evolving landscape of psychiatric treatments. Dr. Krystal was at the forefront of the discovery o
Podcast
Next-Gen Treatments for Anxiety and Depression Disorders
In this episode, Brandon sits down with Shawn Singh, CEO of Vistagen, to discuss a first-of-its-kind approach to treating mental health conditions. Vistagen is developing pherines, a new class of nasal spray treatments that work through nose-to-brain neur
Podcast
Precision Psychiatry and Emerging Technologies
In this episode, Brandon Li sits down with Dr. Jordan Smoller - Jerrold F. Rosenbaum Chair in Psychiatry at Mass General, Co-Director for the Center for Suicide Research and Prevention at MGH and Harvard, Director of the Center for Precision Psychiatry, a
Podcast
From Culture to Care: The Framework of Patient Centricity
How do we move from a system that treats disease to a system that cares for individuals? Dr. Anthony Yanni, Senior Vice President and Global Head of Patient Centricity at Astellas Pharma Inc, has spent his career shaping patient-centricity—and in this epi